Our Story The resilience, agility and shared values of our people has seen us thrive despite the highly competitive and challenging business environment we operate in. We have set ourselves an ambitious five-year corporate goal to be the ‘go to partner’ when commercialising complex medicines in European hospitals, and I am confident we will achieve this as a united and committed team.

Graeme Duncan, CEO Introduction

Welcome to ADVANZ PHARMA, a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by enhancing the critical medicines they depend on.

We could not do this without the resilience and entrepreneurial spirit of our people, the successful collaboration with our partners, and intrinsic guidance of our values to help us achieve our purpose while becoming a truly dynamic, progressive company in the process.

Graeme Duncan, CEO Our Purpose

Our purpose is simple – to improve the lives of patients by enhancing the critical medicines they depend on, broadening patient access and optimising health outcomes.

Our Goal

To become the ‘go to partner’ when commercialising complex medicines in European hospitals.

Our Values

Our values reflect who we are and what we stand for. Having a purpose, goal and values would mean nothing, however, if we didn’t have the people to bring them to life, to share the journey and vision of building a company we believe in. From London to Mumbai, Helsingborg to Sydney and Geneva to Chicago, resilience and common values have united ADVANZ PHARMA, regardless of geography or remote working situation.

Decision Making Global Teams Integrity Openness Entrepreneurial Who We Are?

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by enhancing the critical medicines they depend on.

With the agility of a virtual business but the reassurance that comes with a heritage spanning decades, smart thinking, innovation and a passion for enhancing medicines to broaden access and improve patient health outcomes is at the heart of our business. This is reflected in the work we do, how we do it and the people who deliver it.

As the go to partner for commercialising complex medicines in European hospitals, our highly responsive and experienced teams in marketing, direct sales, market access and medical work across major European markets to broaden access, choice and availability while our established products business with its portfolio of more than 180 molecules provides essential medicines globally to the patients that need them.

ADVANZ PHARMA has an operational headquarters in London, an operations centre of excellence in Mumbai, offices in Geneva and Paris and commercial affiliates in North America, Europe and Australia/NZ, together with an established global network of commercial partners throughout the rest of the world. Our People

The success of any company is driven by its people. We are no different.

Our teams are made up of people who come from all walks of life and backgrounds, and thrive in an environment where diversity is celebrated but where we are all united by the same passion, to help improve the lives of patients by enhancing the critical medicines they depend on.

Our lean and virtual model combined with our responsive and highly experienced teams mean that we are ready to be flexible and adapt to changing situations at a moment’s notice. As a company, we are proud to say we are small enough to care but big enough to make a difference.

Furthermore, ADVANZ PHARMA is committed to investing in the growth of our people and rewarding and recognising the contribution they make while providing a unique culture that includes a collaborative and flexible working environment – our people are encouraged to work up to 3 days a week remotely, helping them operate at the very best of their ability while ensuring work life balance. Our Business

ADVANZ PHARMA is committed to improving patients’ lives by enhancing the critical medicines they depend on. We do this through two distinct business divisions:

– Expanding European Strategic Growth Business Focused on developing and commercialising complex medicines in the European hospitals market.

– Leading, global Established Products Business Diversified portfolio of established medicines with decades of prescription history and proven performance.

Primed for scalability

Both divisions are underpinned by our virtual and lean operating, our leading operations centre of excellence in Mumbai, and our global office locations, providing medical, regulatory, quality and supply-chain capabilities supporting almost 100 countries. It means we are able to acquire and integrate new products and companies quickly and efficiently and are always on the lookout for products that fit our strategic focus so that we can continue to expand and provide clear value to patients and healthcare providers. Our Portfolio

At ADVANZ PHARMA, our European hospital portfolio of complex medicines focuses on Anti- infectives, and Critical Care medicines.

This is bolstered by an established brands business unit of more than 180 molecules sold into 100 countries across a wide range of therapy areas such as CVD, , , , and central nervous system disorders.

Over the years, we have successfully expanded our portfolio through targeted licensing and acquisitions and are well positioned for growth. We continue to work closely with our partners to enhance our medicines and add value through innovation, particularly in the anti-infectives space which has had limited investment in recent years, despite the ever-increasing health burden of antimicrobial resistance. Our focus on complex medicines means building a portfolio of hospital specific products, and enhanced commercial and medical capabilities, in key therapeutic areas such as anti-infectives and endocrinology that bring innovation to improve patient access and health outcomes.

Paul Burden, Chief Commercial Officer, Strategic Growth Business Our Partners

ADVANZ PHARMA is committed to improving the lives of patients by enhancing the critical medicines they depend on.

Partnerships are a fundamental part of this, and are vital to creating new, lasting relationships, where we can continue to invest significantly in products to help broaden patient access and health outcomes.

Why partner with us?

– Close working relationships As highly experienced teams with significant commercial and medical knowledge, we pride ourselves on our close working relationships with manufacturers, distributors and healthcare professionals – something we are very much looking to build upon as we continue to grow the business in Europe.

– Seeking partnerships We are constantly on the lookout for products that fit our strategic focus and channel expertise, that provide clear value to patients and healthcare providers. – Proud heritage and successful track record We have a proud heritage and successful track record of business and product acquisitions. Most recently we completed the acquisition of a portfolio of Alprostadil products from UCB and acquired Correvio Pharma in 2020, increasing our European presence, strengthening our positioning as a trusted partner when commercialising hospital medicines in Europe together with establishing a robust foundation to continue our growth trajectory.

– Actively on the lookout for new growth drivers We continue to invest in our pipeline and aim to add considerably to our portfolio of complex medicines over the next few years with the launch of promising pipeline assets in 2021 and beyond. Our Supply Chain

It goes without saying that the Covid-19 pandemic brought immense pressure to our industry.

Here at ADVANZ PHARMA, we have not wavered on our commitment to deliver essential medicines to those who need them. ADVANZ PHARMA has invested heavily in improving supply continuity, keeping above industry-average inventory levels and having dual sourced supply on critical products which has been crucial during the pandemic.

Many of our medicines are used in intensive care units around the world, whilst others treat chronic conditions that don’t go away simply because the world’s attention is elsewhere – so ensuring continued supply and access has always been our primary aim. A crucial part of this sustained supply and resilience is our focus on collaboration and connectivity with our cross-industry partner network. By keeping a close and proactive dialogue with production lines, manufacturers and shipping – as well as working around the clock – we are able to successfully maintain the supply of critical medicines.

In recent times, we saw our model being tested as demand for certain medicines surged, putting pressure on our systems, yet it passed with flying colours as we continued to provide medicines despite the challenges thrown at it, ensuring patients got the medicines they needed. Our Social Responsibility

Driven by our purpose and values, we take an active approach to charitable work, helping communities at grass roots and encouraging our people to do likewise in their personal lives.

We support SOS Children’s Villages UK, part of the world’s largest charity protecting children who have lost parental care. We also support Snehasadan, a charity in India offering support, a home, education and a future to homeless children. Recently, we raised funds won their behalf to rebuild a children’s home near our Mumbai office.

We donate medicine for hard-to-reach and disaster-hit communities through International Health Partners, Europe’s largest coordinator of donated medicines, supporting patients around the world who cannot otherwise access the medicines they need, reinforcing our purpose of not letting people go without treatment. Supporting communities in crisis Alongside our on-going commitments is a desire to respond to crisis situations, an example of which was our 24-hour dance- a-thon where employees around the world, beginning on the east coast of Australia and ending in the Asia Pacific region, danced around-the-clock to raise tens of thousands of pounds for The British Red Cross Global Coronavirus Fund, an activity which encapsulates the spirit of our people. About Advanz Pharma

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by enhancing the critical medicines they depend on.

We leverage our agile and experienced team to innovate and enhance the critical medicines patients depend on, broadening patient access and improving health outcomes.

With deep expertise in Anti-Infectives, Endocrinology and Critical Care, ADVANZ PHARMA is the go-to-partner when commercialising complex medicines in European hospitals.